Urovant Sciences Ltd. Services Agreements
5 Contracts & Agreements
- Second Amendment to Market Access Services Agreement, dated January 8, 2021, by and between the Company and Sunovion Pharmaceuticals, Inc (Filed With SEC on February 12, 2021)
- First Amendment to Market Access Services Agreement, dated December 21, 2020, by and between the Company and Sunovion Pharmaceuticals, Inc (Filed With SEC on February 12, 2021)
- Market Access Services Agreement, dated June 17, 2020, by and between the Company and Sunovion Pharmaceuticals Inc (Filed With SEC on August 13, 2020)
- Amended and Restated Services Agreement, effective as of July 9, 2018, by and among Roivant Sciences, Inc., Urovant Sciences GmbH, Urovant Sciences, Inc. and the Registrant (Filed With SEC on July 13, 2018)
- Amended and Restated Services Agreement, effective as of July 9, 2018, by and among Roivant Sciences GmbH and Urovant Sciences GmbH (Filed With SEC on July 13, 2018)
